What started as an audition for YG Entertainment in 2012 led Blackpink’s Rose to TIME 100: Most Influential People of 2025. The singer-songwriter recently made it to TIME’s list under the “Pioneers” ...
Shares of Eli Lilly plummeted 14% on Thursday, pacing what would be the stock’s largest loss in decades after the pharmaceutical giant unveiled data for its obesity treatment pill that fell behind ...
It’s been a week of wins for Eli Lilly’s weight-loss drugs. The company’s second-quarter earnings report on Thursday disclosed that sales of Mounjaro, its type 2 diabetes medication often used for ...
Eli Lilly's shares have increased by about 10% over the past month. Clinical progress in the past few weeks has helped solidify its lead in the weight loss market. The company's prospects remain ...
In an Aug. 7 earnings call, Eli Lilly CEO David Ricks told investors that the company plans to submit the drug, orforglipron, to the FDA for approval by the end of the year. Dan Skovronsky, chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback